Original articleProblems in determining occurrence rates of multimorbidity
Introduction
Since the introduction of the term comorbidity [1] a few decades ago, the amount of research in this area has strongly increased. Most of these studies were focused on either the consequences of multiple pathology or the causes of specific combinations or chains of diseases. Specific causes of multimorbidity have, to our knowledge, been little studied so far [2]. Multiple pathology is a highly prevalent health problem and is found to be as frequent as 10% in 0–19-year-olds to 78% in people aged 80 or older [3]. Because of the ageing of the population, and the related increase of the prevalence of chronic diseases, these proportions are expected to rise further. Although there has been increasing interest in research on multiple pathology during recent years, few articles have been published on the methodology of comorbidity and multimorbidity research. As a result, researchers in this field often have to find out by trial and error the most feasible ways to study and analyze multiple pathology.
This article describes some methodological choices and different analytical strategies that have to be considered. The consequences of these strategies are illustrated with examples using data from the Registration Network Family Practices (RNH), a comprehensive general practice-based data system 4, 5 (see Appendix), and from recent studies [3] on the determinants of multimorbidity. The focus is on research using comorbidity or multimorbidity as the dependent variable, but much of the reasoning may also be applicable to studies in which comorbidity or multimorbidity is used as an intermediate or independent variable. This overview may be useful for researchers in critical reading of articles reporting on multiple pathology and in starting studies in this area.
Section snippets
Choices regarding the operationalization of comorbidity and multimorbidity
Before studying determinants or consequences of multiple pathology a number of conceptual decisions have to be made.
Choices regarding the analysis of comorbidity and multimorbidity
Corresponding with the various ways in which multiple pathology is studied, a variety of analytical methods and measures to express the co-occurrence of diseases is available.
Conclusions
Multiple pathology is a health problem that is increasingly important in research because of its prevalence and impact. In this article we reviewed definitions and methods available in relation to conceptual and analytical choices made.
Possible options, both in the design and in the analysis of studies on comorbidity and multimorbidity, should be well considered in advance.
Acknowledgements
The former Dutch “Praeventiefonds” (28-2692) supported this study.
References (30)
- et al.
Marginal impact of psychosocial factors on multimorbidityresults of an explorative nested case-control study
Soc Sci Med
(2000) - et al.
Multimorbidity in general practiceprevalence, incidence, and determinants of co-occurring chronic and recurrent diseases
J Clin Epidemiol
(1998) A note on the selection of control groups and control variables in comorbidity research
Comprehensive Psychiatry
(1993)- et al.
Comorbidity of chronic diseases in general practice
J Clin Epidemiol
(1993) - et al.
The Duke Severity of Illness Checklist (DUSOI) for measurement of severity and comorbidity
J Clin Epidemiol
(1993) - et al.
Unlocking patients' records in general practice for research, medical education and quality assurancethe Registration Network Family Practices
Int J Bio-Medical Comp
(1996) Clinical judgement
(1967)- et al.
Computerized health information in the Netherlandsa registration network of family practices
Br J Gen Pract
(1992) - ...
- et al.
Comorbidity or multimorbiditywhat's in a name? A review of literature
Eur J Gen Pract
(1996)
The clustering of respiratory diseases in early childhood
Fam Med
Comorbidity and treatment planningsummary and future directions
J Cons Clin Psychol
Aging in the eightiesthe prevalence of comorbidity and its association with disability. Advance data from vital and health statistics no. 170
Chronic illness in the community and the concept of social prevalence
Fam Pract
The probability of disease
Proc Annu Symp Comput Appl Med Care
Cited by (169)
Grip strength buffers the harmful association between multimorbidity and depression among middle-aged and older adults
2024, Archives of Gerontology and GeriatricsLongitudinal patterns of comorbidity between anxiety, depression and binge eating symptoms among patients with obesity: A path analysis
2022, Journal of Affective DisordersMultimorbidity, activity limitation and self-reported health all predict mortality risk, but better measures were required
2022, Journal of Clinical EpidemiologyPrecision medicine to manage chronic immune-related conditions
2022, Translational Autoimmunity: Treatment of Autoimmune Diseases